Cargando…
Evidence that justifies reviewing policies of access to medicines for chronic obstructive pulmonary disease in the Brazilian Public Health System
Autores principales: | Pinto, Charleston Ribeiro, Costa, Lindemberg Assunção, Lemos, Antônio Carlos Moreira, Martins, Eduardo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Instituto Israelita de Ensino e Pesquisa Albert Einstein
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7664825/ https://www.ncbi.nlm.nih.gov/pubmed/33237247 http://dx.doi.org/10.31744/einstein_journal/2020CE5754 |
Ejemplares similares
-
Evidence of the association between adherence to treatment and mortality among patients with COPD monitored at a public disease management program in Brazil
por: de Moreira, Aramís Tupiná Alcantara, et al.
Publicado: (2021) -
Management of COPD within the Brazilian Unified Health Care System in the state of Bahia: an analysis of real-life medication use patterns
por: Pinto, Charleston Ribeiro, et al.
Publicado: (2019) -
Local adverse effects associated with the use of
inhaled corticosteroids in patients with moderate or severe asthma
por: Pinto, Charleston Ribeiro, et al.
Publicado: (2013) -
Assessing the severity of medication administration errors identified in an observational study using a valid and reliable method
por: Assunção-Costa, Lindemberg, et al.
Publicado: (2023) -
Access to antiretroviral treatment, issues of well-being and public health governance in Chad: what justifies the limited success of the universal access policy?
por: Azétsop, Jacquineau, et al.
Publicado: (2013)